Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression

被引:101
作者
Coppe, JP [1 ]
Itahana, Y [1 ]
Moore, DH [1 ]
Bennington, JL [1 ]
Desprez, PY [1 ]
机构
[1] Calif Pacific Med Ctr, Inst Canc Res, San Francisco, CA 94115 USA
关键词
D O I
10.1158/1078-0432.CCR-03-0933
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Id proteins are dominant-negative regulators of basic helix-loop-helix transcription factors that control malignant cell behavior in many different tissues. This study aimed to identify the potential role of Id-1 and Id-2 proteins as molecular makers for prostate cancer progression. Experimental Design: Using the technique of immunohistochemistry, we determined Id-1 and Id-2 expression in a panel of 67 human prostate biopsies. We also manipulated Id-1 and Id-2 expression in LNCaP and PC3 prostate cancer cell lines and determined the effects on invasion in vitro, matrix metalloproteinase secretion, and proliferation. Results: Both Id-1 and Id-2 proteins were up-regulated during human prostate cancer progression in vivo and were overexpressed in highly aggressive prostate cancer cells. In vitro, constitutive expression of Id-1, and to a lesser extent Id-2, converted nonaggressive LNCaP prostate cancer cells into more proliferative and invasive cells and increased their secretion of matrix metalloproteinases. Conversely, the down-regulation of Id-2 expression in highly metastatic PC3 cells reduced their growth potential and invasiveness. Conclusions: We propose that both Id-1 and Id-2 proteins control prostate cancer cell phenotypes and could serve as molecular markers of aggressive human prostate cancer.
引用
收藏
页码:2044 / 2051
页数:8
相关论文
共 31 条
[1]   Molecular genetics of prostate cancer [J].
Abate-Shen, C ;
Shen, MM .
GENES & DEVELOPMENT, 2000, 14 (19) :2410-2434
[2]   Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1 [J].
Alani, RM ;
Hasskarl, J ;
Grace, M ;
Hernandez, HC ;
Israel, MA ;
Münger, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) :9637-9641
[3]  
[Anonymous], UROLOGIC PATHOLOGY
[4]  
BOSTWICK DG, 2000, PROSTATE, V14, P2410
[5]   Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array [J].
Chetcuti, A ;
Margan, S ;
Mann, S ;
Russell, P ;
Handelsman, D ;
Rogers, J ;
Dong, QH .
PROSTATE, 2001, 47 (02) :132-140
[6]   Novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1 [J].
Desprez, PY ;
Lin, CQ ;
Thomasset, N ;
Sympson, CJ ;
Bissell, MJ ;
Campisi, J .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (08) :4577-4588
[7]   Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma -: A gene expression analysis on total and microdissected prostate tissue [J].
Ernst, T ;
Hergenhahn, M ;
Kenzelmann, M ;
Cohen, CD ;
Bonrouhi, M ;
Weninger, A ;
Klären, R ;
Gröne, EF ;
Wiesel, M ;
Güdemann, C ;
Küster, J ;
Schott, W ;
Staehler, G ;
Kretzler, M ;
Hollstein, M ;
Gröne, HJ .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06) :2169-2180
[8]   Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis [J].
Fong, S ;
Itahana, Y ;
Sumida, T ;
Singh, J ;
Coppe, JP ;
Liu, Y ;
Richards, PC ;
Bennington, JL ;
Lee, NM ;
Debs, RJ ;
Desprez, PY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13543-13548
[9]   PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING [J].
GLEASON, DF ;
MELLINGE.GT .
JOURNAL OF UROLOGY, 1974, 111 (01) :58-64
[10]   Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends [J].
Howe, HL ;
Wingo, PA ;
Thun, MJ ;
Ries, LAG ;
Rosenberg, HM ;
Feigal, EG ;
Edwards, BK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) :824-842